Background 44 Gamma valerolactone (GVL) is a promising technology for degradation of biomass for biofuel 45 production; however, GVL has adverse toxicity effects on fermentative microbes. Using a 46 combination of chemical genomics and chemical proteomics we sought to understand the 47 mechanism toxicity and resistance to GVL with the goal of engineering a GVL-tolerant, 48 xylose-fermenting yeast.
transform Y133 via high efficiency LiAc transformation. Transformed yeast were plated to 140 YPD+G418 agar plates and incubated until colonies appeared. A total of 50,000 colonies were 141 washed from the plates using 1X PBS, mixed 1:1 with 50% glycerol, and stored at -80 ºC until 142 use. For MoBY-ORF profiling, 25 mL of media containing YPD+2.5% GVL+ G418 was 143 allowed to degas overnight in an anaerobic chamber, and then inoculated with 100 µL of the 144 transformed yeast pool (n=3). Cells were grown for 48h. Genomic DNA was extracted from 1 145 mL from each culture using modified mini-prep with zymolyase and glass beads. Gene specific 146 barcodes were amplified, processed, sequenced, and analyzed as described above. 149 We compared the growth of the Y133 pad1∆ fdc1∆ to the background strain (Y133) in multiple 150 experimental conditions in flasks: YPXD medium (yeast extract 10 g/L, peptone 20 g/L, 151 glucose 20 g/L, and xylose 20 g/L), with 2.5% GVL (aerobic) or 2% GVL (anaerobic, Coy 152 Chamber); anaerobic synthetic hydrolysate (SynH), containing 60 g/L glucose and 30 g/L 153 xylose)+ 1.5% GVL [3] ; aerobic SynH (90g/L glucose and 60 g/L xylose) + 1% GVL. For all 154 experiments, cultures were grown in 25 mL flasks (n=3). Flasks were inoculated with rinsed 155 Y133 or Y133 pad1∆ fdc1∆ cells to bring the initial OD to approximately 0.1. The flasks were 156 grown for 72 hours with agitation anaerobically at 30 °C. 1 mL samples were taken every 24 157 hours. Initial and daily samples were measured for OD and submitted for HPLC analysis to 158 quantify sugar consumption and ethanol production [18] .
Growth and sugar conversion experiments

160
We additionally performed a large scale anaerobic fermentation using 0.5-L bioreactors 161 (BIOSTAT Qplus system from Sartorius, Bohemia, NY, USA) as described in previous work 162 [18] . For these experiments, we used SynH supplemented with FeSO4 (20 µM), sodium citrate 163 (10 uM), and GVL (1.5%). Fermentation was done anaerobically by N2 sparging and pH was 164 controlled at 5. HPLC samples were collected and analyzed as previously described [18] . 165 166 Cell leakage assays 167 A FungaLight TM Cell Viability assay (Invitrogen L34952) was used to determine if GVL 168 caused membrane damage we used using a Guava Flow Cytometer (Millipore, USA) as 169 described previously [19] . Briefly, log-phase cultures were incubated with 0, 2.5, 5, or 10% 170 GVL or EtOH for 4 h at 30 °C. The cells were then stained and immediately read by flow 171 cytometry to determine the population of stained cells (permeable) vs non-stained cells. To test for synergy, a 6X6 dose matrix was initially used to identify potentially synergistic 175 dose combinations, these points were then confirmed in triplicate. 200 µl cultures were grown 176 with combinations with GVL (2%), ethanol (4%), and the relevant single agent and solvent 177 controls with their OD measured after 24 h. Synergy was determined by comparing actual 178 optical density in the presence of compound combinations to an expected value calculated 179 using the multiplicative hypothesis. This assumes that, in the absence of an interaction, each 180 compound would decrease the OD of the cell culture by the same fraction in the presence of 181 the other compound as it does when applied alone, i.e., E = A*B/C, where E is the expected 182 OD, A is OD when compound A is applied alone, B is OD when compound B is applied alone, 183 and C is OD of the control culture (DMSO). In the presence of synergy, the actual OD value 184 is lower than the expected OD. A paired t-test was used to confirm statistical significance of 185 this difference in three replicates of the experiment. Chemical proteomics 196 For yeast proteomics, triplicate 10 mL of YPD + 1 % GVL or YPD were inoculated with the 197 control strain to a starting OD600 of 0.01 and incubated at 30 °C with shaking at 200 rpm. 2 mL 198 of each culture was harvested when they reached an OD600 of ~0.5 (mid log phase growth).
199
Cells were pelleted at 10,000 rpm, the media removed, and stored at −80 °C until processing 200 for proteome analysis. The lower phase was added to the initial collected chloroform phase and the upper phase was 251 discarded. The total sample volume collected was dried in a heat block under a gentle stream 252 of nitrogen.
254
Chloroform was added to all dried sample and standard tubes, mixed and aliquoted for 255 derivatization. MSTFA and anhydrous pyridine were added to all samples and standards, 256 heated, cooled, and transferred to an autosampler vial and were immediately analyzed. To understand the mode of action of GVL toxicity we conducted chemical genomic analysis.
288
This is a reverse genetics method that uses collections of defined gene mutants, and uses the 289 response of these mutants in the presence of a chemical stress to gain functional insight into 290 the chemical's mode of action and cellular target [23] . We first tested the yeast deletion 291 collection with standard rich medium with 2% galactose (YP-Gal) containing 2.3% GVL and 292 used barcode sequencing to identify the fitness response of the individual deletion mutants.
294
We identified 843 significantly responsive deletion mutants (p<0.01, Supplementary   295 Information 2). Among the top 10 sensitive deletion mutants, we found significant enrichment 296 for genes involved in late endosome to vacuole transport (p<0.01, Fig. 2a) , driven by deletion 297 mutants of SEC28, VPS38, DID2. We validated the mutants within this Gene Ontology (GO) 298 category by testing single mutants individually, and found all gave a lower IC50 compared to 299 the control strain (Fig. 2b) . Deletion mutants of these 3 genes exhibit increased sensitivity to 300 ethanol, heat, the ionophore nigercin, and the ergosterol biosynthesis inhibitor miconazole [24-301 29]. When we correlated the chemical genomic profile of GVL with the yeast genetic 302 interaction network database [30] , we found significant enrichment for genes involved in golgi-303 vesicle mediated transport among the top 10 correlations (p=0.001). RET2 was consistently 304 predicted as the top correlation for the GVL chemical genomic profile. Ret2p is a subunit of 305 the coatomer complex involved in retrograde transport between Golgi and ER is also involved 306 in golgi transport of vesicles [31] . RET2 mutants similarity show increased sensitivity to heat 307 and membrane disrupting agents [24, 26] . We correlated the chemical genomic profile of GVL 308 to existing chemical genomic datasets [23] , and found its profile was significantly similar to 309 profiles of the ionophore nigericin (p<0.01) and the phosphotidylserine targeting agent 310 papuamide (p<0.01), [23] . Taken together, these data suggest GVL could exert toxicity by 311 damaging membrane integrity. 
GVL damages membranes and is synergistic with ethanol 314
To confirm if GVL treatment can rapidly affect cell integrity, we assessed cell permeability 315 after GVL treatment. Using flow cytometry combined with a dye that is only taken up by cells 316 with damaged membranes, we found a rapid and dose dependent effect of GVL on permeability 317 (Fig. 3a,b) , similar to the effects of ethanol but with a greater magnitude (Fig. 3b) . Given that 318 both GVL and ethanol can damage cellular membranes, we also tested if these compounds are 319 synergistic. We found a strong synergism between GVL and ethanol in both our lab strain and 320 xylose fermenting strain (Fig. 3c) . At a 2% GVL concentration and 4% ethanol concentration, 321 we observed significant synergism in membrane damage between GVL and ethanol (p<0.01).
322
This suggest that as ethanol titers increase during fermentation, the toxic effects of GVL and 323 ethanol will magnify each other, which ultimately will affect yield.
325
Deletion of Pad1p and Fdc1p enhance GVL tolerance 326 Importantly for our goal, we also investigated gene deletions that increased resistance to GVL.
327
Among the top GVL-resistant mutants we found a significant enrichment for genes involved 328 in phenylpropanoid metabolic process (p<0.002, Fig. 4a) , driven by deletion mutants of PAD1 329 and FDC1. Single mutant validations reveal deletion of these genes improved GVL tolerance 330 (Fig. 4b) . Pad1p is responsible for generating a co-factor needed by Fdc1p to decarboxylate 331 phenolic acids [32-34].
333
Overexpression chemical genomic profiling confirms Pad1p mediates GVL toxicity 334 We wanted to extend our chemical genomic analysis to an industrially relevant, xylose ferment 335 yeast strain. At present, there are no available genome-wide deletion mutant collections in 336 industrial yeast, so we took a complementary approach using overexpression plasmids that 337 could be introduced to any yeast. The MoBY-ORF 2.0 plasmid collection, which encodes 338 barcoded versions of 95% of all S. cerevisiae genes each expressed on a 2µ plasmid [35] , 339 enabled this approach. This collection of plasmids can be pooled and transformed into any 340 yeast to allow investigations of the effect of gene dose under stress conditions. We transformed 341 a version of the xylose-fermenting yeast Y133 [36] en masse with the pooled plasmid collection 342 and selected over 50K individual transformants (10X genome coverage). We grew this pooled 343 transformant collection in the presence of 2.5% GVL or a water control under anaerobic 344 conditions in glucose/xylose-containing media and assessed the effects of increased gene dose 345 on growth in the presence of GVL. We found the Pad1p overexpression mutant was one of the 346 top sensitive strains (p<0.01, Fig. 4c ). We confirmed with single mutant cultures that 347 overexpression of PAD1 causes GVL sensitivity. The IC50 of Y133+pPAD1 was 2.2 %, 348 compared to 2.56 % of vector control (Fig. 4d, p<0.001) . of PAD1 and downstream of FDC1 (Fig. 5a) . We confirmed deletion of both genes by PCR 357 (Fig. 5b) .
359
The IC50 concentration of GVL for the Y133 pad1∆ fdc1∆ strain was significantly higher than 360 for the Y133 parent (Fig. 5c, p<0 .01). We tested for GVL tolerance in flask experiments under 361 anaerobic and aerobic conditions in both rich and defined media (Supplementary 362 Information 3a-d). In all conditions, the Y133 pad1∆ fdc1∆ mutant had greater growth than 363 the Y133 strain. Additionally, the tolerant strain had greater initial glucose/xylose use, and 364 ethanol production under anaerobic conditions. Finally, we tested the performance of the Y133 365 pad1∆ fdc1∆ strain in a scaled-up fermentation experiment, under industrially relevant 366 anaerobic conditions in a synthetic hydrolysate containing 1.5% GVL. The engineered grew, 367 consumed sugar, and produced significantly more ethanol after 24 h, and had consumed 368 significantly more xylose after 28 h (p<0.05) (Fig. 5d) . To further understand the mechanism of GVL tolerance of the Y133 pad1∆ fdc1∆ strain, we 374 used quantitative proteomics to identify how GVL treatment alters protein abundance in the 375 Y133 and Y133 pad1∆ fdc1∆ strain (Supplementary Information 4) . Among the top 20 376 proteins that had increased abundance in the Y133 pad1∆ fdc1∆ versus the Y133 background 377 (Fig. 6a) , we observed a significant enrichment for proteins involved in ergosterol (Erg11p, 378 Erg5p, Hmg1p, P=0.009). Interestingly, among the top 20 proteins that had decreased 379 abundance in the presence of GVL (Fig. 6a) , the Y133 pad1∆ fdc1∆ strain had significantly 380 enrichment in for genes involved in protein folding (Hsp26p, Hsp82p, Fes1p, Sse2p, Ssa3p, 381 Ssa4p; P=9.2e -5 ), which suggests GVL may further exert toxicity by affecting protein folding 382 in non-resistant strains. 383 384 Y133 pad1∆ fdc1∆ produces more ergosterol in response to GVL 385 Ergosterol is a fungal membrane sterol that determines membrane fluidity, and by 386 extension can affect thermal tolerance and tolerance of solvents such as ethanol [37] . Given 387 that proteins involved in ergosterol biosynthesis have increased abundance in the Y133 pad1∆ 388 fdc1∆ strain compared to the background, we wanted to test in the engineered, GVL-tolerant 389 strain had greater ergosterol content than the parent strain. In untreated SynH medium, the 390 engineered strain produced significantly more ergosterol compared to the parent strain ( Fig.   391   6b) . This difference was magnified in the presence of 1% GVL, where the engineered strain 392 significantly increased ergosterol production, whereas the parent strain had decreased 393 ergosterol content (Fig. 6b) . 394 
395
Discussion
396
Using chemical genetics, we discovered that deletion of the functionally related genes PAD1 397 and FDC1 genes confers resistance to GVL in a xylose-fermenting yeast strain, presumably by 398 increasing ergosterol production. Over expression of these genes have been shown to confer 399 resistance to the lignocellulose-derived inhibitors cinnamic acid and ferulic acid [38] [39] [40] .
400
Considering this result, yeast harboring PAD1/FDC1 overexpression systems may be 401 incompatible with GVL-produced hydrolysates, and the biocatalyst used should be tailored to 402 the hydrolysate to minimize the effects of process-derived inhibitors (e.g., GVL, ionic liquids), 403 lignocellulose derived inhibitors (e.g., phenolic acids), and end-product inhibitors (e.g.,
Conclusions 435
We have elucidated the mechanism of -valerolactone toxicity in Saccharomyces 436 cerevisiae. Like ethanol, the non-polar solvent GVL compromises membrane integrity, leading 437 to cell lysis. Further, GVL is synergistic with ethanol in toxicity, thus reducing the amount of 438 residual GVL in GVL-produced hydrolysates is critical for not only GVL recovery economics, 439 but also ensuring maximum ethanol titers during fermentation. Given the general effects of 440 GVL on membranes, it is likely that this mechanism of toxicity is similar in prokaryotic 441 biocatalysts. Competing interests 456 The authors declare that they have no competing interests. 
